anipamil has been researched along with verapamil in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, R; Pasini, E; Poli, E; Raddino, R | 1 |
| Lyakishev, AA; Orekhov, AN; Tertov, VV | 1 |
| Albertini, A; Boraso, A; Cargnoni, A; Ferrari, R; Pasini, E; Raddino, R | 1 |
| Dillon, JS; Nayler, WG | 1 |
| Ceconi, C; Curello, S; Ferrari, R; Ghielmi, S; Raddino, R; Visioli, O | 1 |
| Curtis, MJ; Walker, MJ; Yuswack, T | 1 |
| Guppy, LJ; Harvie, CJ; Pugsley, MK; Ries, CR; Walker, MJ | 1 |
7 other study(ies) available for anipamil and verapamil
| Article | Year |
|---|---|
Effects of the novel calcium channel blocker, anipamil, on the isolated rabbit heart. Comparison with verapamil and gallopamil.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Female; Gallopamil; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Propylamines; Rabbits; Verapamil | 1992 |
Use of cultured atherosclerotic cells for investigation of antiatherosclerotic effects of anipamil and other calcium antagonists.
Topics: Aorta; Arteriosclerosis; Calcium Channel Blockers; Cell Division; Cells, Cultured; Cholesterol; Endothelium, Vascular; Humans; Lipids; Nifedipine; Propylamines; Verapamil | 1991 |
Effects of anipamil on myocardial sarcolemmal and mitochondrial calcium transport, comparison with verapamil and nifedipine.
Topics: Adenosine Triphosphate; Animals; Ca(2+) Mg(2+)-ATPase; Calcium; In Vitro Techniques; Kinetics; Magnesium; Male; Mitochondria, Heart; Myocardial Reperfusion; Myocardium; Nifedipine; Oxygen Consumption; Propylamines; Rabbits; Sarcolemma; Verapamil | 1990 |
The Ca2+ -antagonist and binding properties of the phenylalkylamine, anipamil.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Calcium Chloride; Electric Stimulation; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Propylamines; Rats; Rats, Inbred Strains; Verapamil | 1988 |
Prolonged protective effect of the calcium antagonist anipamil on the ischemic reperfused rabbit myocardium: comparison with verapamil.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Creatine Kinase; In Vitro Techniques; Mitochondria, Heart; Myocardial Reperfusion; Myocardium; Oxygen Consumption; Phosphocreatine; Propylamines; Proteins; Rabbits; Verapamil | 1989 |
Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Electrocardiography; Heart Rate; Propylamines; Rats; Verapamil | 1986 |
Effects of anipamil, a long acting analog of verapamil, in pigs subjected to myocardial ischemia.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Dose-Response Relationship, Drug; Hemodynamics; Male; Myocardial Ischemia; Propylamines; Swine; Time Factors; Verapamil | 1995 |